| Financial Year |
March 31 2023 |
| Monetary Funds |
4,350,913,141.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
22,184,034.25 |
| Accounts Receivable |
4,718,187,456.91 |
| Advances to Suppliers |
213,122,606.92 |
| Other Receivables |
14,510,056.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
555,741.71 |
| Dividend Receivable |
-- |
| Inventories |
603,525,603.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
411,650,143.42 |
| Total Current Assets |
10,334,523,041.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,091,414,306.19 |
| Investment Properties |
2,805,024.34 |
| Fixed Assetes |
27,113,789,001.49 |
| Under-construction Projects |
331,284,445.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
465,950,600.91 |
| R&D expenses |
-- |
| Goodwill |
55,824,989.69 |
| Long-Term Deferred and Prepaid Expenses |
15,450,724.94 |
| Deferred Income Tax Assets |
232,517,132.87 |
| Other Non-Current Assets |
646,792,360.01 |
| Sub-Total of Non-Current Assets |
38,599,646,780.75 |
| Total Assets |
48,934,169,822.69 |
| Short-Term Loans |
1,733,397,309.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,401,185,455.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
50,825,319.30 |
| Taxes Payable |
130,218,051.85 |
| Interest Payable |
7,174,505.52 |
| Dividend Payable |
4,849,987.37 |
| Other payables |
179,814,142.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,554,254,547.40 |
| Other Current Liabilities |
13,125,696.08 |
| Sub-Total of Current Liabilities |
7,125,778,618.77 |
| Long-term Loans |
14,363,436,656.44 |
| Bonds Payable |
1,218,100,971.10 |
| Long-Term Accounts Payable |
755,648,153.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
8,533,333.33 |
| Deferred Income Tax Liabilities |
74,455,640.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,468,622,599.08 |
| Total Liabilities |
23,594,401,217.85 |
| Paid-In Capital(Or Share Stock) |
4,195,438,342.00 |
| Capital Surplus |
6,257,738,282.15 |
| Surplus Reserve |
938,763,537.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,904,485,561.85 |
| Minority Stockholder's Interest |
4,798,536,903.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,541,231,700.96 |
| Owner's Equity（Stockholder's Equity） |
25,339,768,604.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
48,934,169,822.69 |
